Laxmi Dental Ipo
Objects of the Issue
Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our Company.
Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings
Funding the capital expenditure requirements for purchase of new machinery for our Company.*
Investment in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery
General corporate purposes.
Laxmi Dental IPO Review
IPO Watch – Apply
Canara Bank Securities – Apply
Capital Market – May Apply
IPO Lead Managers aka Merchant Bankers
Motilal Oswal Investment Advisors Limited
SBI Capital Markets Limited
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 33 | ₹14,124 |
| Retail Maximum | 14 | 462 | ₹1,97,736 |
| S-HNI Minimum | 15 | 495 | ₹2,11,860 |
| B-HNI Minimum | 71 | 2,343 | ₹10,02,804 |
| IPO Open Date: | January 13, 2025 |
| IPO Close Date: | January 15, 2025 |
| Basis of Allotment: | January 16, 2025 |
| Refunds: | January 17, 2025 |
| Credit to Demat Account: | January 17, 2025 |
| IPO Listing Date: | January 20, 2025 |
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹1,38.07 | ₹1,43.40 | ₹18.68 | ₹102.75 |
| 2023 | ₹1,63.84 | ₹1,67.76 | ₹4.16 | ₹96.54 |
| 2024 | ₹1,95.26 | ₹1,86.66 | ₹25.23 | ₹134.52 |
| Sept 2024 | ₹1,17.99 | ₹1,03.41 | ₹22.74 | ₹158.22 |
| KPI | Values |
| ROE: | 78.78% |
| ROCE: | 19.97% |
| EBITDA Margin: | 12.29% |
| PAT Margin: | 13.03% |
| Debt to equity ratio: | 0.94 |
| Earning Per Share (EPS): | ₹5.11 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 78.78% |
| Net Asset Value (NAV): | ₹8.63 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| PolyMedicure Limited | 26.92 | 94.02 | 19.05 | 153.22 | 14,34.54 Cr. |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| IPO Open Date: | January 13, 2025 |
| IPO Close Date: | January 15, 2025 |
| Face Value: | ₹2 Per Equity Share |
| IPO Price Band: | ₹407 to ₹428 Per Share |
| Issue Size: | Approx ₹698.06 Crores |
| Fresh Issue: | Approx ₹138 Crores |
| Offer for Sale: | Approx ₹560.06 Crores, 1,30,85,467 Equity Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 10% |
| QIB Quota: | Not more than 75% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |